These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8543554)

  • 1. Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.
    Freeman EW; Rickels K; Sondheimer SJ; Wittmaack FM
    J Clin Psychiatry; 1996 Jan; 57(1):7-11. PubMed ID: 8543554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
    Halbreich U; Smoller JW
    J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
    Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
    JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response to sertraline treatment of severe premenstrual syndromes.
    Freeman EW; Sondheimer SJ; Polansky M; Garcia-Espagna B
    J Clin Psychiatry; 2000 Aug; 61(8):579-84. PubMed ID: 10982201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
    Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
    Kornstein SG; Pearlstein TB; Fayyad R; Farfel GM; Gillespie JA
    J Clin Psychiatry; 2006 Oct; 67(10):1624-32. PubMed ID: 17107257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
    Young SA; Hurt PH; Benedek DM; Howard RS
    J Clin Psychiatry; 1998 Feb; 59(2):76-80. PubMed ID: 9501889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
    Pearlstein TB; Halbreich U; Batzar ED; Brown CS; Endicott J; Frank E; Freeman EW; Harrison WM; Haskett RF; Stout AL; Yonkers KA
    J Clin Psychiatry; 2000 Feb; 61(2):101-9. PubMed ID: 10732657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
    Lydiard RB; Stahl SM; Hertzman M; Harrison WM
    J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
    Bennie EH; Mullin JM; Martindale JJ
    J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
    Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline in the treatment of premenstrual dysphoric disorder.
    Yonkers KA; Halbreich U; Freeman E; Brown C; Pearlstein T
    Psychopharmacol Bull; 1996; 32(1):41-6. PubMed ID: 8927673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
    J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant.
    Freeman EW; Rickels K; Arredondo F; Kao LC; Pollack SE; Sondheimer SJ
    J Clin Psychopharmacol; 1999 Feb; 19(1):3-8. PubMed ID: 9934936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
    Thase ME; Blomgren SL; Birkett MA; Apter JT; Tepner RG
    J Clin Psychiatry; 1997 Jan; 58(1):16-21. PubMed ID: 9055832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
    Thase ME; Fava M; Halbreich U; Kocsis JH; Koran L; Davidson J; Rosenbaum J; Harrison W
    Arch Gen Psychiatry; 1996 Sep; 53(9):777-84. PubMed ID: 8792754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
    Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
    Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.